C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2501095
This invention provides methods to predict the likelihood of occurrence of the side effect of edema in patients treated with a drug including, but not limited to, a TKI, such as Imatinib or GLEEVEC.TM./GLIVEC®. The methods employed use gene expression profile comparisons and the determination of specific SNPs and in the IL-1.beta. gene. Methods of treatment of edema and kits for the performance of the above assays are also provided.
L'invention concerne des méthodes permettant de prévoir la probabilité d'apparition d'effets secondaires oedémateux chez des patients traités par médicaments comprenant, sans aspect limitatif, un inhibiteur de tyrosine kinase (TKI), comme Imatinib ou GLEEVEC<SP>TM</SP>/GLIVEC ®. Les méthodes utilisées font appel à des comparaisons de profils d'expression génique et à la détermination de SNP spécifiques et dans le gène IL-1.beta.. L'invention concerne également des méthodes de traitement de l'oedème et des trousses appropriées pour effectuer les dosages biologiques mentionnés précédemment.
Dressman Marlene Michelle
Kudaravalli Sridhar
Malinowski Rachel Helene
Mc Lean Lee Anne
Polymeropoulos Mihael Hristos
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Methods to predict edema as a side effect of drug treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to predict edema as a side effect of drug treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to predict edema as a side effect of drug treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799087